Optain Health

Optain Health is an AI-enabled medical device and software company specializing in non-invasive retinal imaging technology for preventive disease screening and detection. The company offers an integrated turnkey solution comprising a portable automatic fundus camera and proprietary Software as a Medical Device (SaMD) that leverages AI algorithms to analyze full-color retinal images in real-time. Optain's platform screens for diabetic retinopathy, glaucoma, age-related macular degeneration, and cardiovascular disease risk, enabling clinicians to identify referable conditions and risk-stratify patients efficiently. The technology supports three stakeholder segments: healthcare providers (streamlined workflow and standardized care), patients (detailed health insights), and insurers (population health screening and risk stratification). Founded in 2023 and backed by $26 million in Series A funding, Optain combines clinical expertise with advanced AI to democratize access to specialized eye disease screening while reducing diagnostic delays and improving health equity across diverse populations.